 TARRYTOWN, N.Y., July 01, 2021 GLOBE NEWSWIRE -- Prestige Consumer Healthcare Inc. NYSE:PBH Prestige or the Company today announced that it has completed the previously announced acquisition of TheraTears and other over-the-counter consumer brands. The closing was finalized pursuant to the terms of the asset purchase agreement which was initially announced on May 27, 2021, under which Prestige agreed to acquire the brands from specialty pharmaceutical company, Akorn Operating Company LLC Akorn, for 230 million in cash. The acquisition of TheraTears will further enhance Prestiges leading eye care portfolio and generate additional long-term growth opportunities for the Company. 